MRK

Merck & Co
D

MRK

Arincen67/100B

Merck & Co shares outstanding 1985–2026

Merck & Co had 2,467,171,640 shares outstanding on 8 November 2026. Merck & Co had 2.48B diluted shares on average over the last twelve months, down 1.7% on the twelve months before. In fiscal year 2025 the average was 2.51B.

Last updated 7 Nov 2026 · Next report 2 Feb 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 20262.48B-1.72%2.47B
FY202531 Dec 20252.51B-1.34%2.50B
FY202431 Dec 20242.54B-0.24%2.53B
FY202331 Dec 20232.55B+0.20%2.55B
FY202231 Dec 20222.54B+0.16%2.53B
FY202131 Dec 20212.54B-0.12%2.53B
FY202031 Dec 20202.54B-1.51%2.53B
FY201931 Dec 20192.58B-3.70%2.57B
FY201831 Dec 20182.68B-2.51%2.59B
FY201731 Dec 20172.75B-1.40%2.70B
FY201631 Dec 20162.79B-1.90%2.75B
FY201531 Dec 20152.84B-2.97%2.78B
FY201431 Dec 20142.93B-2.27%2.84B
FY201331 Dec 20133.00B-2.60%2.93B
FY201231 Dec 20123.08B-0.58%3.03B
FY201131 Dec 20113.09B-0.83%3.04B
FY201031 Dec 20103.12B+37.25%3.10B
FY200931 Dec 20092.27B+6.08%2.11B
FY200831 Dec 20082.14B-2.28%2.14B
FY200731 Dec 20072.19B+0.24%2.17B
FY200631 Dec 20062.19B-0.58%2.18B
FY200531 Dec 20052.20B-1.17%2.20B
FY200431 Dec 20042.23B-1.19%2.22B
FY200331 Dec 20032.25B-1.05%2.24B
FY200231 Dec 20022.28B-1.95%2.26B
FY200131 Dec 20012.32B-1.31%2.29B
FY200031 Dec 20002.35B-2.14%2.31B
FY199931 Dec 19992.40B-1.49%2.35B
FY199831 Dec 19982.44B-1.07%2.37B
FY199731 Dec 19972.47B-0.83%2.40B
FY199631 Dec 19962.49B-2.01%2.43B
FY199531 Dec 19952.54B-0.52%2.47B
FY199431 Dec 19942.55B+9.58%2.51B
FY199331 Dec 19932.33B+23.26%2.30B
FY199231 Dec 19921.89B-18.95%1.87B
FY199131 Dec 19912.33B-0.52%2.31B
FY199031 Dec 19902.34B-1.26%2.34B
FY198931 Dec 19892.37B+0.31%2.37B
FY198831 Dec 19882.37B-3.41%2.37B
FY198731 Dec 19872.45B-2.11%2.45B
FY198631 Dec 19862.50B-2.66%2.50B
FY198531 Dec 19852.57B—2.57B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Merck & Co's shares

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.